Ouwehand
Arthur Ouwehand, Inkoo FI
Patent application number | Description | Published |
---|---|---|
20090311227 | Composition - The present invention relates to a composition comprising: i) at least one strain of a | 12-17-2009 |
20100092429 | Composition - The present invention provides a composition comprising: (a) one or more live | 04-15-2010 |
Arthur Ouwehand, Palo Alto, CA US
Patent application number | Description | Published |
---|---|---|
20140356329 | PROBIOTICS FOR USE IN REDUCING THE INCIDENCE AND DURATION OF ILLNESS - The present invention provides probiotic compositions suitable for reducing the incidence and duration of human illness. In particular, the present invention provides methods and compositions suitable for preventing disease in young children. In some particularly preferred embodiments, the present invention finds use in the prevention respiratory disease in children. | 12-04-2014 |
Arthur Ouwehand, Inga FI
Patent application number | Description | Published |
---|---|---|
20100040579 | PROBIOTICS FOR USE IN REDUCING THE INCIDENCE AND DURATION F ILLNESS - The present invention provides probiotic compositions suitable for reducing the incidence and duration of human illness. In particular, the present invention provides methods and compositions suitable for preventing disease in young children. In some particularly preferred embodiments, the present invention finds use in the prevention respiratory disease in children. | 02-18-2010 |
20100189692 | PROBIOTICS FOR USE IN REDUCING EOSINOPHILIA AND RESPIRATORY ALLERGIES - The present invention provides probiotic compositions suitable for reducing the incidence and duration of nasal eosinophilia and other parameters associated with birch pollen allergy. In some embodiments, the present invention provides methods and/or compositions suitable for reducing nasal and/or respiratory allergy symptoms. | 07-29-2010 |
20110033423 | PROBIOTICS FOR USE IN RELIEVING SYMPTOMS ASSOCIATED WITH GASTROINTESTINAL DISORDERS - The present invention provides probiotic compositions suitable for relieving symptoms associated with gastrointestinal disorders. In particular, the present invention provides compositions and methods to relieve symptoms associated with functional bowel disorders, irritable bowel syndrome, functional diarrhea, functional bloating, and other symptoms. | 02-10-2011 |
20140065209 | PROBIOTIC BACTERIA FOR THE TOPICAL TREATMENT OF SKIN DISORDERS - The present invention relates to a probiotic bacteria, and/or soluble metabolite of a probiotic bacteria and/or a cell lysate of a probiotic bacteria for use in the treatment of a disorder associated with Tight Junction function, characterised in that the probiotic bacteria, soluble metabolite of a probiotic bacteria and/or a cell lysate of a probiotic bacteria is formulated for topical administration. | 03-06-2014 |
20140242034 | PROBIOTICS FOR USE IN RELIEVING SYMPTOMS ASSOCIATED WITH GASTROINTESTINAL DISORDERS - The present invention provides probiotic compositions suitable for relieving symptoms associated with gastrointestinal disorders. In particular, the present invention provides compositions and methods to relieve symptoms associated with functional bowel disorders, irritable bowel syndrome, functional diarrhea, functional bloating, and other symptoms. | 08-28-2014 |
20150224153 | PROBIOTICS FOR USE IN REDUCING EOSINOPHILIA AND RESPIRATORY ALLERGIES - The present invention provides probiotic compositions suitable for reducing the incidence and duration of nasal eosinophilia and other parameters associated with birch pollen allergy. In some embodiments, the present invention provides methods and/or compositions suitable for reducing nasal and/or respiratory allergy symptoms. | 08-13-2015 |
Arthur Constantijn Ouwehand, Inga FI
Patent application number | Description | Published |
---|---|---|
20100203026 | PROBIOTICS FOR INDUCING SATIETY AND/OR SATIATION - The invention relates to the field of nutrition and medicine. Provided are compositions, bacterial strains and methods for inducing or enhancing satiety and satiation and for treating or preventing obesity, overweight and overweight related diseases. | 08-12-2010 |
Cornelis Ouwehand, Amsterdam NL
Patent application number | Description | Published |
---|---|---|
20120055846 | HYDROCRACKING CATALYST - Process of preparing a hydrocracking catalyst carrier comprising amorphous binder and zeolite Y, which process comprises subjecting zeolite Y having a silica to alumina molar ratio of at least 10 to calcination at a temperature of from 700 to 1000° C., hydrocracking catalyst carrier comprising amorphous binder and zeolite Y having a silica to alumina molar ratio of at least 10, the infrared spectrum of which catalyst has a peak at 3690 cm | 03-08-2012 |
20150209772 | PROCESS FOR PREPARING HYDROCRACKING CATALYST - Process for preparing a sulphided hydrocracking catalyst comprising the steps of (a) treating an amorphous silica alumina carrier with one or more Group VIB metal components, one or more Group VIII metal components and a C | 07-30-2015 |
20160074846 | HYDROCRACKING CATALYST - Process for preparing a hydrocracking catalyst carrier which process comprises subjecting a carrier comprising an amorphous binder and zeolite Y having a silica to alumina molar ratio of at least 10 to calcination at a temperature of from 700 to 900° C., hydrocracking catalyst carrier comprising amorphous binder and zeolite Y having a silica to alumina molar ratio of at least 10, the infrared spectrum of which catalyst has a peak at 3690 cm | 03-17-2016 |
Cornelis Ouwehand, Purmerend NL
Patent application number | Description | Published |
---|---|---|
20100278723 | ZEOLITE Y - Process for preparing a modified zeolite Y which process comprises subjecting zeolite Y having a silica to alumina molar ratio of at least 10 to calcination at a temperature of from 700 to 1000° C. wherein (i) the steam partial pressure is at most 0.06 bar at a temperature of from 700 to 800° C., (ii) the steam partial pressure is at most 0.08 bar at a temperature of from 800 to 850° C. , (iii) the steam partial pressure is at least 0.03 bar at a temperature of from 850 to 900° C., and (iv) the steam partial pressure is at least 0.05 bar at a temperature of from 900 to 950° C. and (v) the steam partial pressure is at least 0.07 bar at a temperature of from 950 to 1000° C., a modified zeolite Y obtainable by such process, zeolite Y having a silica to alumina molar ratio of at least 10, the infrared spectrum of which has a peak at 3700 cm | 11-04-2010 |
Cornelius Ouwehand, Purmerend NL
Patent application number | Description | Published |
---|---|---|
20140135560 | ZEOLITE Y - Process for preparing a modified zeolite Y which process comprises subjecting zeolite Y having a silica to alumina molar ratio of at least 10 to calcination at a temperature of from 700 to 1000° C. wherein (i) the steam partial pressure is at most 0.06 bar at a temperature of from 700 to 800° C., (ii) the steam partial pressure is at most 0.08 bar at a temperature of from 800 to 850° C., (iii) the steam partial pressure is at least 0.03 bar at a temperature of from 850 to 900° C., and (iv) the steam partial pressure is at least 0.05 bar at a temperature of from 900 to 950° C. and (v) the steam partial pressure is at least 0.07 bar at a temperature of from 950 to 1000° C., a modified zeolite Y obtainable by such process, zeolite Y having a silica to alumina molar ratio of at least 10, the infrared spectrum of which has a peak at 3700 cm | 05-15-2014 |
Jan-Willem Ouwehand, Katwijk NL
Patent application number | Description | Published |
---|---|---|
20090148241 | REMOVAL OF PLATFORMS AT SEA - The present invention relates tot a method of removing an upper part of a platform which rests on a seabed and which extends above the waterline, the platform comprising legs which extend upwards from the seabed, the method comprising the subsequent steps of: | 06-11-2009 |
Krista Ouwehand, Leiden NL
Patent application number | Description | Published |
---|---|---|
20160069868 | MOLECULAR TARGETS AND COMPOUNDS, AND METHODS TO IDENTIFY THE SAME, USEFUL IN THE TREATMENT OF FIBROSIS - The present invention relates to methods and assays for identifying agents useful in the treatment of fibrotic diseases, in particular diseases related to fibroblast migration and differentiation. The invention provides polypeptide and nucleic acid TARGETs, siRNA sequences based on these TARGETs and antibodies against the TARGETs. The invention is further related to pharmaceutical composition comprising siRNA sequences based on the TARGETs and antibodies against the TARGETs for use in the treatment of fibrotic disease. The invention further provides in vitro methods for inhibition of fibroblast migration and differentiation. | 03-10-2016 |
Luberthus Ouwehand, 'S-Hertogenbosch NL
Patent application number | Description | Published |
---|---|---|
20080309915 | METHOD FOR CORRECTING DISTURBANCES IN A LEVEL SENSOR LIGHT PATH - The invention relates to a level sensor for determining a height of a substrate. The level sensor generates one or more measurement beam and directs the measurement beam to a measurement spot on the substrate and produces a reflected measurement beam. The level sensor also generates one or more reference beams. A detector detects both the reflected measurement beam and the reference beam, respectively, and produces a measurement signal and a reference signal, respectively, the measurement signal being indicative for the height at the measurement spot. A processor that receives these signals and corrects the measurement signal based on the reference signal. The level sensor has an optical arrangement in a predetermined area close to where the substrate is to be located. The measurement beam and the reference beam propagate along substantially equal optical paths of propagation in the predetermined area. The optical arrangement deviates the reference beam from the substantially equal optical paths of propagation in the predetermined area such that the at least one reference beam does not hit the substrate. | 12-18-2008 |
Wil Ouwehand, Katwijk NL
Patent application number | Description | Published |
---|---|---|
20090274555 | Multiple-stage centrifugal pump of inline design - The present invention relates to a multiple-stage centrifugal pump of inline design, comprising a connection housing ( | 11-05-2009 |
Willem Ouwehand, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20090317413 | DETECTION OF HUMAN PLATELET ANTIGEN (HPA) ANTIBODIES - This invention relates to recombinant GPIIIa molecules that lack the ligand binding βA domain and bind to HPA-1 antibodies in monomeric form. These GPIIIa molecules can be recombinantly expressed at high levels and may be useful, for example, in the detection of HPA-1 antibodies. Such detection may be useful, for example, in the diagnosis and therapy of HPA antibody disorders such as Neonatal Alloimmune Immune Thrombocytpenia (NAIT), Post Transfusion Purpura (PTP) and Platelet Refractoriness (PR). | 12-24-2009 |
20150111296 | Transcription Factor Mediated Programming Towards Megakaryocytes - This invention relates to the forward programming of pluripotent stem cells (PSCs) into megakaryocyte (MK) progenitor cells using the transcription factors GATA1, FLI1 and TAL1. Methods of producing megakaryocyte (MK) progenitor cells and subsequently differentiating them into mature megakaryocytes are provided. | 04-23-2015 |
Willem Ouwehand, London GB
Patent application number | Description | Published |
---|---|---|
20110021759 | Diagnosis and Treatment of Blood Disorders - Based on the discovery of the nucleotide and amino acid differences which distinguish the Gov | 01-27-2011 |